Skip to main content
Premium Trial:

Request an Annual Quote

Kinexus Launches Proteomics Database Featuring 1.5M Phosphorylation Measurements

Premium

Kinexus Bioinformatics this week launched its new KiNET-Antibody Microarray website, an open-access database containing more than 1.5 million measurements of the phosphorylation levels of 400 protein kinases and their targets in more than 2,000 tissue and cell specimens.

The data was generated in-house at Kinexus using its Kinex antibody microarrays, a product the company launched in March as part of its ongoing plan to enter the microarray vendor business after having operated mainly as a service provider since its launch more than a decade ago (PM 03/18/2011).

The biological samples used to generate the database were obtained over the last five years from more 600 academic and industrial groups, the company said in a statement.

The KiNET-AM database follows on the Kinexus' KiNET-Immunoblotting database, which was launched in 2005 and contains more than 200,000 measurements of protein phosphorylation and expression as determined by the company's Kinetworks immunoblotting platform.

Kinexus also maintains its PhosphoNet KnowledgeBase database, which contains data on more than 93,000 experimentally confirmed human protein phosphorylation sites and an additional 560,000 predicted sites.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.